219 related articles for article (PubMed ID: 34764821)
21. Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.
Yoshimura K; Inoue Y; Tsuchiya K; Karayama M; Yamada H; Iwashita Y; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Lung Cancer; 2020 Mar; 141():21-31. PubMed ID: 31931443
[TBL] [Abstract][Full Text] [Related]
22. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
[TBL] [Abstract][Full Text] [Related]
24. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
25. The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD-L1 expression and tumor-infiltrating lymphocytes.
Chen L; Cao MF; Zhang X; Dang WQ; Xiao JF; Liu Q; Tan YH; Tan YY; Xu YY; Xu SL; Yao XH; Cui YH; Zhang X; Bian XW
Cancer Med; 2019 Dec; 8(17):7207-7218. PubMed ID: 31605439
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
[TBL] [Abstract][Full Text] [Related]
27. CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Rocha P; Salazar R; Zhang J; Ledesma D; Solorzano JL; Mino B; Villalobos P; Dejima H; Douse DY; Diao L; Mitchell KG; Le X; Zhang J; Weissferdt A; Parra-Cuentas E; Cascone T; Rice DC; Sepesi B; Kalhor N; Moran C; Vaporciyan A; Heymach J; Gibbons DL; Lee JJ; Kadara H; Wistuba I; Behrens C; Solis LM
Cancer Immunol Immunother; 2021 Jul; 70(7):1965-1976. PubMed ID: 33416944
[TBL] [Abstract][Full Text] [Related]
28. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
Tang XJ; Zhou QH; Zhang SF; Liu LX
Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
[TBL] [Abstract][Full Text] [Related]
29. Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer.
Ma K; Li YX; Guo QQ
Neoplasma; 2022 Sep; 69(5):1092-1100. PubMed ID: 35951452
[TBL] [Abstract][Full Text] [Related]
30. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
31. Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.
Wang H; Xia Y; Yu J; Guan H; Wu Z; Ban D; Wang M
HLA; 2019 Jul; 94(1):39-48. PubMed ID: 30953385
[TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of STK11 with different mutation status and its relationship with tumor-infiltrating immune cells in non-small cell lung cancer.
Zheng J; Deng Y; Huang B; Chen X
Front Immunol; 2024; 15():1387896. PubMed ID: 38736875
[TBL] [Abstract][Full Text] [Related]
33. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
34. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
35. Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma.
Ma W; Liang J; Mo J; Zhang S; Hu N; Tian D; Chen Z
BMC Cancer; 2021 Oct; 21(1):1096. PubMed ID: 34635082
[TBL] [Abstract][Full Text] [Related]
36. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
38. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
Hu K; Yao L; Yan Y; Zhou L; Li J
Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]